Mazes of Nrf2 regulation

Biochemistry (Moscow)

Volumn 82, Issue 5, 2017, Pages 556-564

  Zenkov, N K ^a   Kozhin, P M ^a   Chechushkov, A V ^a   Martinovich, G G ^b   Kandalintseva, N V ^c   Menshchikova, E B ^a  

^a Research Institute of Experimental and Clinical Medicine   (Russian Federation)

^b BELARUSIAN STATE UNIVERSITY   (Belarus)

^c NOVOSIBIRSK STATE PEDAGOGICAL UNIVERSITY   (Russian Federation)

Author keywords

autophagy; epigenetic regulation; Nrf2 transcription factor; ubiquitination

Indexed keywords

ATP DEPENDENT 26S PROTEASE; KEAP1 PROTEIN, HUMAN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; NFE2L2 PROTEIN, HUMAN; PROTEASOME; TRANSCRIPTION FACTOR NRF2; TUMOR PROTEIN;

ANIMAL; AUTOPHAGY; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; NEOPLASM; OXIDATIVE STRESS; RADIATION TOLERANCE; UBIQUITINATION;

ANIMALS; AUTOPHAGY; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; NEOPLASM PROTEINS; NEOPLASMS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; RADIATION TOLERANCE; TRANSCRIPTION, GENETIC; UBIQUITINATION;

EID: 85019864860     PISSN: 00062979     EISSN: 16083040     Source Type: Journal    
DOI: 10.1134/S0006297917050030     Document Type: Review

References (81)

1. Chevillard, G., and Blank, V. (2011) NFE2L3 (NRF3): the Cinderella of the Cap’n’Collar transcription factors, Cell. Mol. Life Sci., 68, 3337–3348.
2. Kim, H. M., Han, J. W., and Chan, J. Y. (2016) Nuclear factor erythroid-2 like 1 (NFE2L1): structure, function and regulation, Gene, 584, 17–25.
3. Zhang, X., and Mosser, D. M. (2008) Macrophage activation by endogenous danger signals, J. Pathol., 214, 161–178.
4. Chapple, S. J., Keeley, T. P., Mastronicola, D., Arno, M., Vizcay-Barrena, G., Fleck, R., Siow, R. C., and Mann, G. E. (2016) Bach1 differentially regulates distinct Nrf2-dependent genes in human venous and coronary artery endothelial cells adapted to physiological oxygen levels, Free Radic. Biol. Med., 92, 152–162.
5. Biswas, M., and Chan, J. Y. (2010) Role of Nrf1 in antioxidant response elementmediated gene expression and beyond, Toxicol. Appl. Pharmacol., 244, 16–20.
6. Canning, P., Sorrell, F. J., and Bullock, A. N. (2015) Structural basis of Keap1 interactions with Nrf2, Free Radic. Biol. Med., 88, 101–107.
7. Jaramillo, M. C., and Zhang, D. D. (2013) The emerging role of the Nrf2-Keap1 signaling pathway in cancer, Genes Dev., 27, 2179–2191.
8. Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., and Hayes, J. D. (2015) Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease, Free Radic. Biol. Med., 88, 108–146.
9. Katsuoka, F., and Yamamoto, M. (2016) Small Maf proteins (MafF, MafG, MafK): history, structure and function, Gene, 586, 197–205.
10. Zhang, Y., and Xiang, Y. (2016) Molecular and cellular basis for the unique functioning of Nrf1, an indispensable transcription factor for maintaining cell homoeostasis and organ integrity, Biochem. J., 473, 961–1000.
11. Wang, H., Liu, K., Geng, M., Gao, P., Wu, X., Hai, Y., Li, Y., Luo, L., Hayes, J. D., Wang, X. J., and Tang, X. (2013) RXRα inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2, Cancer Res., 73, 3097–3108.
12. Chowdhry, S., Zhang, Y., McMahon, M., Sutherland, C., Cuadrado, A., and Hayes, J.D. (2013) Nrf2 is controlled by two distinct beta-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity, Oncogene, 32, 3765–3781.
13. β-TrCP1/2 E3 ligase substrates, Mol. Cell. Proteom., 14, 1781–1795.
14. Dodson, M., Redmann, M., Rajasekaran, N. S., Darley-Usmar, V., and Zhang, J. (2015) KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity, Biochem. J., 469, 347–355.
15. Cuadrado, A. (2015) Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3/β-TrCP, Free Radic. Biol. Med., 88, 147–157.
16. Ma, Q., Battelli, L., and Hubbs, A. F. (2006) Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidantactivated transcription factor Nrf2, Am. J. Pathol., 168, 1960–1974.
17. Ahmed, S. M., Luo, L., Namani, A., Wang, X. J., and Tang, X. (2017) Nrf2 signaling pathway: pivotal roles in inflammation, Biochim. Biophys. Acta, 1863, 585–597.
18. Kim, J., and Keum, Y. S. (2016) NRF2, a key regulator of antioxidants with two faces towards cancer, Oxid. Med. Cell. Longev., 2016, 2746457.
19. Sita, G., Hrelia, P., Tarozzi, A., and Morroni, F. (2016) Isothiocyanates are promising compounds against oxidative stress, neuroinflammation and cell death that may benefit neurodegeneration in Parkinson’s disease, Int. J. Mol. Sci., 17, 1454.
20. Zhang, R., Xu, M., Wang, Y., Xie, F., Zhang, G., and Qin, X. (2016) Nrf2–a promising therapeutic target for defensing against oxidative stress in stroke, Mol. Neurobiol., in press.
21. Zenkov, N. K., Menshchikova, E. B., and Tkachev, V. O. (2013) Keap1/Nrf2/ARE redoxsensitive signaling system as a pharmacological target, Biochemistry (Moscow), 78, 19–36.
22. Smith, E. J., Shay, K. P., Thomas, N. O., Butler, J. A., Finlay, L. F., and Hagen, T. M. (2015) Agerelated loss of hepatic Nrf2 protein homeostasis: potential role for heightened expression of miR-146a, Free Radic. Biol. Med., 89, 1184–1191.
23. Suzuki, T., and Yamamoto, M. (2015) Molecular basis of the Keap1-Nrf2 system, Free Radic. Biol. Med., 88, 93–100.
24. Harder, B., Jiang, T., Wu, T., Tao, S., Rojo de la Vega, M., Tian, W., Chapman, E., and Zhang, D. D. (2015) Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention, Biochem. Soc. Trans., 43, 680–686.
25. Iso, T., Suzuki, T., Baird, L., and Yamamoto, M. (2016) Absolute amounts and status of Nrf2-Keap1-Cul3 complex within cells, Mol. Cell. Biol., 36, 3100–3112.
26. Zhu, J., Wang, H., Chen, F., Fu, J., Xu, Y., Hou, Y., Kou, H. H., Zhai, C., Nelson, M. B., Zhang, Q., Andersen, M. E., and Pi, J. (2016) An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy, Free Radic. Biol. Med., 99, 544–556.
27. Holland, R., Hawkins, A. E., Eggler, A. L., Mesecar, A. D., Fabris, D., and Fishbein, J. C. (2008) Prospective type 1 and type 2 disulfides of Keap1 protein, Chem. Res. Toxicol., 21, 2051–2060.
28. Wu, T., Zhao, F., Gao, B., Tan, C., Yagishita, N., Nakajima, T., Wong, P. K., Chapman, E., Fang, D., and Zhang, D. D. (2014) Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis, Genes Dev., 28, 708–722.
29. Lewis, K. N., Wason, E., Edrey, Y. H., Kristan, D. M., Nevo, E., and Buffenstein, R. (2015) Regulation of Nrf2 signaling and longevity in naturally longlived rodents, Proc. Natl. Acad. Sci. USA, 112, 3722–3727.
30. Zhang, D. D., Lo, S. C., Sun, Z., Habib, G. M., Lieberman, M. W., and Hannink, M. (2005) Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasomeindependent pathway, J. Biol. Chem., 280, 30091–30099.
31. Jiang, T., Harder, B., Rojo de la Vega, M., Wong, P. K., Chapman, E., and Zhang, D. D. (2015) p62 links autophagy and Nrf2 signaling, Free Radic. Biol. Med., 88, 199–204.
32. Katsuragi, Y., Ichimura, Y., and Komatsu, M. (2015) p62/SQSTM1 functions as a signaling hub and an autophagy adaptor, FEBS J., 282, 4672–4678.
33. Rogov, V., Dotsch, V., Johansen, T., and Kirkin, V. (2014) Interactions between autophagy receptors and ubiquitinlike proteins form the molecular basis for selective autophagy, Mol. Cell., 53, 167–178.
34. Copple, I. M., Lister, A., Obeng, A. D., Kitteringham, N. R., Jenkins, R. E., Layfield, R., Foster, B. J., Goldring, C. E., and Park, B. K. (2010) Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway, J. Biol. Chem., 285, 16782–16788.
35. Jain, A., Lamark, T., Sjottem, E., Larsen, K. B., Awuh, J. A., Overvatn, A., McMahon, M., Hayes, J. D., and Johansen, T. (2010) p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response elementdriven gene transcription, J. Biol. Chem., 285, 22576–22591.
36. Ichimura, Y., Waguri, S., Sou, Y. S., Kageyama, S., Hasegawa, J., Ishimura, R., Saito, T., Yang, Y., Kouno, T., Fukutomi, T., Hoshii, T., Hirao, A., Takagi, K., Mizushima, T., Motohashi, H., Lee, M. S., Yoshimori, T., Tanaka, K., Yamamoto, M., and Komatsu, M. (2013) Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy, Mol. Cell, 51, 618–631.
37. Ishimura, R., Tanaka, K., and Komatsu, M. (2014) Dissection of the role of p62/Sqstm1 in activation of Nrf2 during xenophagy, FEBS Lett., 588, 822–828.
38. Rhee, S. G., and Bae, S. H. (2015) The antioxidant function of sestrins is mediated by promotion of autophagic degradation of Keap1 and Nrf2 activation and by inhibition of mTORC1, Free Radic. Biol. Med., 88, 205–211.
39. Bryan, H. K., Olayanju, A., Goldring, C. E., and Park, B. K. (2013) The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation, Biochem. Pharmacol., 85, 705–717.
40. Huang, Y., Li, W., Su, Z. Y., and Kong, A. N. (2015) The complexity of the Nrf2 pathway: beyond the antioxidant response, J. Nutr. Biochem., 26, 1401–1413.
41. Niture, S. K., and Jaiswal, A. K. (2009) Prothymosin-α mediates nuclear import of the INrf2/Cul3 Rbx1 complex to degrade nuclear Nrf2, J. Biol. Chem., 284, 13856–13868.
42. Jain, A. K., and Jaiswal, A. K. (2006) Phosphorylation of tyrosine 568 controls nuclear export of Nrf2, J. Biol. Chem., 281, 12132–12142.
43. Jain, A. K., Mahajan, S., and Jaiswal, A. K. (2008) Phosphorylation and dephosphorylation of tyrosine 141 regulate stability and degradation of INrf2: a novel mechanism in Nrf2 activation, J. Biol. Chem., 283, 17712–17720.
44. Hardie, D. G., Ross, F. A., and Hawley, S. A. (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis, Nat. Rev. Mol. Cell Biol., 13, 251–262.
45. Joo, M. S., Kim, W. D., Lee, K. Y., Kim, J. H., Koo, J. H., and Kim, S. G. (2016) AMPK facilitates nuclear accumulation of Nrf2 by phosphorylating at serine 550, Mol. Cell. Biol., 36, 1931–1942.
46. Zenkov, N. K., Chechushkov, A. V., Kozhin, P. M., Kandalintseva, N. V., Martinovich, G. G., and Menshchikova, E. B. (2016) Plant phenols and autophagy, Biochemistry (Moscow), 81, 297–314.
47. Liu, X., Li, H., Liu, L., Lu, Y., Gao, Y., Geng, P., Li, X., Huang, B., Zhang, Y., and Lu, J. (2016) Methylation of arginine by PRMT1 regulates Nrf2 transcriptional activity during the antioxidative response, Biochim. Biophys. Acta, 1863, 2093–2103.
48. Yang, P., Hu, S., Yang, F., Guan, X. Q., Wang, S. Q., Zhu, P., Xiong, F., Zhang, S., Xu, J., Yu, Q. L., and Wang, C. Y. (2014) Sumoylation modulates oxidative stress relevant to the viability and functionality of pancreatic β cells, Am. J. Transl. Res., 6, 353–360.
49. Kawai, Y., Garduno, L., Theodore, M., Yang, J., and Arinze, I. J. (2011) Acetylationdeacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization, J. Biol. Chem., 286, 7629–7640.
50. Chen, Z., Ye, X., Tang, N., Shen, S., Li, Z., Niu, X., Lu, S., and Xu, L. (2014) The histone acetylranseferase hMOF acetylates Nrf2 and regulates antidrug responses in human nonsmall cell lung cancer, Br. J. Pharmacol., 171, 3196–3211.
51. Cheng, X., Ku, C. H., and Siow, R. C. (2013) Regulation of the Nrf2 antioxidant pathway by microRNAs: new players in micromanaging redox homeostasis, Free Radic. Biol. Med., 64, 4–11.
52. Guo, Y., Yu, S., Zhang, C., and Kong, A. N. (2015) Epigenetic regulation of Keap1-Nrf2 signaling, Free Radic. Biol. Med., 88, 337–349.
53. Wagner, A. E., Terschluesen, A. M., and Rimbach, G. (2013) Health promoting effects of brassicaderived phytochemicals: from chemopreventive and antiinflammatory activities to epigenetic regulation, Oxid. Med. Cell. Longev., 2013, 964539.
54. Khor, T. O., Fuentes, F., Shu, L., Paredes-Gonzalez, X., Yang, A. Y., Liu, Y., Smiraglia, D. J., Yegnasubramanian, S., Nelson, W. G., and Kong, A. N. (2014) Epigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancer, Cancer Prev. Res., 7, 1186–1197.
55. Chartoumpekis, D. V., Wakabayashi, N., and Kensler, T. W. (2015) Keap1/Nrf2 pathway in the frontiers of cancer and noncancer cell metabolism, Biochem. Soc. Trans., 43, 639–644.
56. Kang, K. A., Piao, M. J., Ryu, Y. S., Kang, H. K., Chang, W. Y., Keum, Y. S., and Hyun, J. W. (2016) Interaction of DNA demethylase and histone methyltransferase upregulates Nrf2 in 5-fluorouracilresistant colon cancer cells, Oncotarget, 7, 40594–40620.
57. Ayers, D., Baron, B., and Hunter, T. (2015) miRNA influences in NRF2 pathway interactions within cancer models, J. Nucleic Acids, 2015, 143636.
58. Forman, H. J. (2016) Redox signaling: an evolution from free radicals to aging, Free Radic. Biol. Med., 97, 398–407.
59. Lu, M. C., Ji, J. A., Jiang, Z. Y., and You, Q. D. (2016) The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update, Med. Res. Rev., 36, 924–963.
60. Zhang, D. D., Lo, S. C., Cross, J. V., Templeton, D. J., and Hannink, M. (2004) Keap1 is a redoxregulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex, Mol. Cell. Biol., 24, 10941–10953.
61. Baird, L., and Dinkova-Kostova, A. T. (2013) Diffusion dynamics of the Keap1-Cullin3 interaction in single live cells, Biochem. Biophys. Res. Commun., 433, 58–65.
62. Liby, K. T., and Sporn, M. B. (2012) Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease, Pharmacol. Rev., 64, 972–1003.
63. Wilson, A. J., Kerns, J. K., Callahan, J. F., and Moody, C. J. (2013) Keap calm, and carry on covalently, J. Med. Chem., 56, 7463–7476.
64. Abed, D. A., Goldstein, M., Albanyan, H., Jin, H., and Hu, L. (2015) Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agents, Acta Pharm. Sin. B, 5, 285–299.
65. Jiang, Z. Y., Lu, M. C., Xu, L. L., Yang, T. T., Xi, M. Y., Xu, X. L., Guo, X. K., Zhang, X. J., You, Q. D., and Sun, H. P. (2014) Discovery of potent Keap1–Nrf2 protein–protein interaction inhibitor based on molecular binding determinants analysis, J. Med. Chem., 57, 2736–2745.
66. Lu, M. C., Yuan, Z. W., Jiang, Y. L., Chen, Z. Y., You, Q. D., and Jiang, Z. Y. (2016) A systematic molecular dynamics approach to the study of peptide Keap1–Nrf2 protein–protein interaction inhibitors and its application to p62 peptides, Mol. Biosyst., 12, 1378–1387.
67. Ghorab, M. M., Alsaid, M. S., Higgins, M., Dinkova-Kostova, A. T., Shahat, A. A., Elghazawy, N. H., and Arafa, R. K. (2016) Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel 2-phenylquinazolin-4-amine derivatives, J. Enzyme Inhib. Med. Chem., 31, 1612–1618.
68. Hancock, R., Bertrand, H. C., Tsujita, T., Naz, S., El-Bakry, A., Laoruchupong, J., Hayes, J. D., and Wells, G. (2012) Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction, Free Radic. Biol. Med., 52, 444–451.
69. Clements, C. M., McNally, R. S., Conti, B. J., Mak, T. W., and Ting, J. P. (2006) DJ-1, a cancerand Parkinson’s diseaseassociated protein, stabilizes the antioxidant transcriptional master regulator Nrf2, Proc. Natl. Acad. Sci. USA, 103, 15091–15096.
70. Yu, M., Li, H., Liu, Q., Liu, F., Tang, L., Li, C., Yuan, Y., Zhan, Y., Xu, W., Li, W., Chen, H., Ge, C., Wang, J., and Yang, X. (2011) Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway, Cell. Signal., 23, 883–892.
71. Lee, D. F., Kuo, H. P., Liu, M., Chou, C. K., Xia, W., Du, Y., Shen, J., Chen, C. T., Huo, L., Hsu, M. C., Li, C. W., Ding, Q., Liao, T. L., Lai, C. C., Lin, A. C., Chang, Y. H., Tsai, S. F., Li, L. Y., and Hung, M. C. (2009) KEAP1 E3 ligasemediated downregulation of NF-κB signaling by targeting IKKβ, Mol. Cell, 36, 131–140.
72. Lo, S. C., and Hannink, M. (2006) PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redoxregulated Keap1-dependent ubiquitin ligase complex, J. Biol. Chem., 281, 37893–37903.
73. Kang, H. J., Hong, Y. B., Kim, H. J., and Bae, I. (2010) CR6-interacting factor 1 (CRIF1) regulates NF-E2-related factor 2 (NRF2) protein stability by proteasomemediated degradation, J. Biol. Chem., 285, 21258–21268.
74. Hampton, M. B., and O’Connor, K. M. (2016) Peroxiredoxins and the regulation of cell death, Mol. Cells, 39, 72–76.
75. Jeong, C. H., and Joo, S. H. (2016) Downregulation of reactive oxygen species in apoptosis, J. Cancer Prev., 21, 13–20.
76. Murakami, S., and Motohashi, H. (2015) Roles of Nrf2 in cell proliferation and differentiation, Free Radic. Biol. Med., 88, 168–178.
77. Blaser, H., Dostert, C., Mak, T. W., and Brenner, D. (2016) TNF and ROS crosstalk in inflammation, Trends Cell Biol., 26, 249–261.
78. Redmann, M., Darley-Usmar, V., and Zhang, J. (2016) The role of autophagy, mitophagy and lysosomal functions in modulating bioenergetics and survival in the context of redox and proteotoxic damage: implications for neurodegenerative diseases, Aging Dis., 7, 150–162.
79. Chen, Y., Zhang, H., Zhou, H. J., Ji, W., and Min, W. (2016) Mitochondrial redox signaling and tumor progression, Cancers (Basel), 8, 40.
80. Xiang, M., Namani, A., Wu, S., and Wang, X. (2014) Nrf2: bane or blessing in cancer? J. Cancer Res. Clin. Oncol., 140, 1251–1259.
81. Gacesa, R., Dunlap, W. C., Barlow, D. J., Laskowski, R. A., and Long, P. F. (2016) Rising levels of atmospheric oxygen and evolution of Nrf2, Sci. Rep., 6, 27740.